All Posts Archives - EverGlade

All Posts

NSF X-Labs Funding Targets Bioengineering: From Protein Sequence to Function

Leave a Comment / All Posts, Life Sciences, NSF / By

The National Science Foundation (NSF) has announced From Sequence to Function, a new NSF X-Labs topic supporting platform technologies that connect protein sequence and structure to predictable, controllable biological function. Written proposals are due February 8, 2027, at 5:00 PM Eastern. NSF anticipates one or more Other Transaction (OT) awards under the topic. Issued through

NSF X-Labs Funding Targets Bioengineering: From Protein Sequence to Function Read More »

NIAID Releases 2027 Omnibus BAA for Vaccines, Therapeutics, and Diagnostics

Leave a Comment / All Posts, Life Sciences, NIAID / By

The National Institute of Allergy and Infectious Diseases (NIAID) has released its 2027 Division of Microbiology and Infectious Diseases (DMID) Omnibus Broad Agency Announcement (BAA) to advance medical interventions for infectious diseases. The solicitation covers three research areas: needle-free vaccines, therapeutic candidates, and in vitro diagnostic platforms. Full proposals for all three areas must be

NIAID Releases 2027 Omnibus BAA for Vaccines, Therapeutics, and Diagnostics Read More »

DARPA Releases Official HUBBLE Solicitation to Map Human Protein Interactions

Leave a Comment / All Posts, DARPA, Life Sciences / By

The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released the official solicitation for High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE). The program seeks computational capabilities to map human protein-protein interactions and identify new diagnostic and therapeutic targets for traumatic brain injury (TBI). Required abstracts are due

DARPA Releases Official HUBBLE Solicitation to Map Human Protein Interactions Read More »

Building a Virtual Cell Starts With Better Biological Data

Leave a Comment / All Posts, DOE, Emerging Technologies, Industry News, Life Sciences / By

On October 7, Biohub, The National Institutes of Health (NIH), and U.S. Department of Energy (DOE) announced a major expansion of an international effort to generate open, AI-ready data for predictive models of biology. The partners describe a $1.8 billion combination of funding, data, computation, and new measurement technology. The long-term goal is a virtual

Building a Virtual Cell Starts With Better Biological Data Read More »

FY2027 Federal Funding Choosing Where to Focus-Blog

The FY2027 Federal Funding Strategy Playbook: Webinar Recap

Leave a Comment / All Posts, Events, Industry News / By

Date: September 24, 2026 Hosted by: EverGlade and QNova LifeSciences Meet the Panelists Laura Powell, PhD, PMP, Director, Technical Team Lead, EverGlade Tyler Kessler, Director, Finance Team Lead, EverGlade Stephen Richardson, Head of Strategic Partnerships, EverGlade Jim Sergi, President and Founder, QNova LifeSciences Topics We Covered Federal agency activity and opportunities heading into FY2027 Consortia,

The FY2027 Federal Funding Strategy Playbook: Webinar Recap Read More »

ARPA-H Launches SURPASS to Advance Simulation-Augmented, Real-Time Adaptive Clinical Trials

Leave a Comment / All Posts, ARPA-H, Emerging Technologies, Life Sciences / By

The Advanced Research Projects Agency for Health’s (ARPA-H) Proactive Health Office has released Innovative Solutions Opening (ISO) ARPA-H SOL 26 164 for the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program. SURPASS seeks to establish persistent, multi-arm clinical trial platforms that integrate simulation, accumulating human data, prespecified adaptations, shared operational infrastructure, and reusable regulatory assets.

ARPA-H Launches SURPASS to Advance Simulation-Augmented, Real-Time Adaptive Clinical Trials Read More »

BARDA’s “Protection Before Day One” Initiative Seeks Broadly Protective Influenza Vaccines

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a draft Request for Project Proposals (RPP) for “Protection Before Day One” (PBD1), Solicitation No. RRPV 26-08-PBD1. The initiative seeks to close a central pandemic preparedness gap: the time between identifying a novel pandemic influenza strain and deploying

BARDA’s “Protection Before Day One” Initiative Seeks Broadly Protective Influenza Vaccines Read More »

DARPA APM Solicitation Opens for Programmable Precision Polymers

Leave a Comment / All Posts, DARPA, Defense, Life Sciences / By

The Defense Advanced Research Projects Agency’s (DARPA) Multi X Office has released the official solicitation for Atomically Precise Molecules (APM), seeking new polymer synthesis approaches that can deliver precisely controlled materials with breakthrough nonlinear optical performance. Required proposal abstracts are due October 27, 2026, at 1:00 p.m. ET, with full proposals due December 18, 2026,

DARPA APM Solicitation Opens for Programmable Precision Polymers Read More »

DOE Seeks Industry Input on Critical Mineral Recovery and Reuse

Leave a Comment / All Posts, DOE, Energy / By

The Department of Energy’s Office of Environmental Management (DOE-EM) is seeking industry input on recovering and repurposing surplus critical minerals and materials from its inventory. The Expression of Interest (EOI) explores potential collaborations that could strengthen domestic supply chains and support U.S. scientific, manufacturing, and energy needs. Responses are due November 2, 2026, with a virtual

DOE Seeks Industry Input on Critical Mineral Recovery and Reuse Read More »

BARDA BioMaP Seeks Agile, Distributed Drug Manufacturing for Medical Countermeasures

Leave a Comment / All Posts, BARDA, Life Sciences / By

The Biomedical Advanced Research and Development Authority (BARDA) has released has released a Request for Project Proposals through Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP), seeking U.S.-based teams that can develop and commercialize agile, distributed manufacturing capacity for medical countermeasures. RPP 26-13-EDM focuses on end-to-end production of small-molecule drug substances and finished drug products, from key starting

BARDA BioMaP Seeks Agile, Distributed Drug Manufacturing for Medical Countermeasures Read More »

DARPA Firefox Seeks Scalable Technologies for High-Resolution, Noninvasive Brain-Computer Interface

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

Download the Solicitation The Defense Advanced Research Projects Agency’s (DARPA) Biological Technologies Office (BTO) has released the Firefox Program Solicitation, DARPA-PS-26-137, to advance a scalable, noninvasive brain-computer interface (BCI). The program seeks to build on DARPA’s existing coherent optical sensing system by addressing two scale up barriers: steering coherent light across multiple neural sensing regions

DARPA Firefox Seeks Scalable Technologies for High-Resolution, Noninvasive Brain-Computer Interface Read More »

ARPA-H Launches SPECTRA Program to Advance Autism Research, Precision Care, and Quality of Life

Leave a Comment / All Posts, ARPA-H, Emerging Technologies, Life Sciences / By

The Advanced Research Projects Agency for Health (ARPA-H) has released the Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) solicitation, a new Proactive Health Office program focused on improving how autism is understood, assessed, and supported across the lifespan. SPECTRA seeks multidisciplinary research and development efforts that can identify individual developmental and health

ARPA-H Launches SPECTRA Program to Advance Autism Research, Precision Care, and Quality of Life Read More »

Scroll to Top